Thursday, January 12, 2017 3:06:19 PM
iocept, Inc. (NASDAQ:BIOC) stock is presently standing at about $2.71 and lots of equity research firms seem to have a target price set on the stock. And a quick view of analyst notes show that 0 are rating the stock a buy while 0 rate BIOC a strong buy. There are 0 equity research firms advocating a Hold and 0 consider it Sell.
http://theindependentrepublic.com/2017/01/12/what-wall-street-is-saying-about-biocept-inc-nasdaqbioc/
Recent BIOCQ News
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 11/20/2023 01:47:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM